“We are wildly ambitious,” Tom Insel, M.D., says when asked about his plans for Verily Life Sciences, a research organization parented by Google. After 13 years, Insel rocked the world of brain science when he announced plans to step down as director of the National Institute of Mental Health (NIMH) in late 2015. His departure from NIMH, however, wasn’t a leave from neuroscience research or public health; it was a progressive step towards advancing the technologies that are predicted to transform mental health care.
Recently, Insel was profiled in the July/August 2017 issue of The Atlantic, which offers a thorough look at the trajectory that took him from lead role at the world’s largest mental health research institution to complete submersion in the energetic tech bubble of Silicon Valley.
The article recounts Insel’s early work in behavioral research, as well as his influence on the field of antidepressants and NIMH’s involvement in clinical drug trials. Presented with an opportunity to direct a new mental health team under Google, he could now focus on taking applied research and use it to help millions of people globally, who are in need of mental health care. “At any given moment, roughly one in seven of the world’s 7.5 billion people is struggling with mental illness. ‘We’re not going to reach all those people by hiring more psychiatrists,’ says Insel. But we might reach them with smartphones.”